Max Planck Institute of Molecular Physiology Oct 16 2024 mRNA-based therapeutics and vaccines are the new hope in the fight against incurable diseases. A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still a great challenge. The team of Peter ‘t Hart, group leader at the Chemical Genomics Centre at the Max Planck Institute of Molecular Physiology has